Abstract
Although overweight and obesity have long been recognised as major risk factors for a number of chronic diseases, lifestyle developments have led to substantial increases in bodyweight worldwide. In addition to their negative effects on health and quality of life, obesity and associated comorbidities may have a considerable impact on healthcare expenditures. The aim of this systematic review was to summarise cost estimates and compare costs attributable to obesity across different European countries. A structured search in MEDLINE, EMBASE, and all EBM Reviews was conducted to identify relevant literature. Two researchers independently assessed publications according to pre-defined inclusion criteria and with regard to study methodology. Costs attributable to obesity were extracted from the included studies and calculated relative to country-specific gross domestic income. Out of 797 publications that met our search criteria, 13 studies investigating 10 Western European countries were determined to be relevant and included in our review. Obesity-related healthcare burdens of up to 10.4 billion euros were found. Reported relative economic burdens ranged from 0.09% to 0.61% of each country’s gross domestic product (GDP). Obesity appears to be responsible for a substantial economic burden in many European countries, and the costs identified in the available studies presumably reflect conservative estimates. There remains a great need for prospective and standardised studies to provide more accurate estimates of costs for all European countries.
Similar content being viewed by others
Abbreviations
- BGD:
-
Between-group differences
- BMI:
-
Body mass index
- CHF:
-
Swiss francs
- DG:
-
Dutch gulden
- EU:
-
European Union
- FF:
-
French francs
- GDP:
-
Gross domestic product
- ICD:
-
International Classification of Disease
- IASO:
-
International Association for the Study of Obesity
- Mesh:
-
Medical subject heading
- n.a.:
-
Not available
- NS:
-
Not significant
- SEK:
-
Swedish crowns
- UK:
-
United Kingdom
- Yrs:
-
Years
References
Popkin BM, Kim S, Rusev ER, Du S, Zizza C. Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obes Rev. 2006;7(3):271–93.
Ezzati M, Lopez AD, Rodgers A, Vander HS, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347–60.
Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197–209.
International Association for the Study of Obesity. Global Obesity Prevalence in Adults. http://www.iaso.org 2006 September 1;Available from: URL: http://www.iaso.org.
Fry J, Finley W. The prevalence and costs of obesity in the EU. Proc Nutr Soc. 2005;64(3):359–62.
Martinez JA, Kearney JM, Kafatos A, Paquet S, Martinez-Gonzalez MA. Variables independently associated with self-reported obesity in the European Union. Public Health Nutr. 1999;2(1A):125–33.
Federal Statistical Office. Federal Health Monitoring Information Services. Federal Statistical Office Germany, Wiesbaden 2007. Available from: URL: www.destatis.de.
Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res. 1998;6(2):97–106.
Thompson D, Edelsberg J, Kinsey KL, Oster G. Estimated economic costs of obesity to U.S. business. Am J Health Promot. 1998;13(2):120–7.
European Central Bank . Fixed euro conversion rates. 2007. Available from: URL: http://www.ecb.eu/bc/intro/html/index.en.html. Accessed 2007.
FXHistory: historical currency exchange rates. Oanda com—The currency site 2007. Available from: URL: http://www.oanda.com/convert/fxhistory.
European gross domestic product in billion US-Dollars. International Monetary Fund. 2007. Available from: URL: http://www.imf.org/.
Borg S, Persson U, Odegaard K, Berglund G, Nilsson JA, Nilsson PM. Obesity, survival, and hospital costs-findings from a screening project in Sweden. Value Health. 2005;8(5):562–71.
Narbro K, Jonsson E, Larsson B, Waaler H, Wedel H, Sjostrom L. Economic consequences of sick-leave and early retirement in obese Swedish women. Int J Obes Relat Metab Disord. 1996;20(10):895–903.
Narbro K, Agren G, Jonsson E, Naslund I, Sjostrom L, Peltonen M. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med. 2002;162(18):2061–9.
von Lengerke T, Reitmeir P, John J. Direct medical costs of (severe) obesity: a bottom-up assessment of over- vs. normal-weight adults in the KORA-study region (Augsburg, Germany). Gesundheitswesen. 2006;68(2):110–5.
Sander B, Bergemann R. Economic burden of obesity and its complications in Germany. Eur J Health Econ. 2003;4(4):248–53.
Schneider R. Relevanz und Kosten der Adipositas in Deutschland (Relevance and cost of obesity in Germany). Ernährungs-Umschau. 1996;43(10):369–74.
Detournay B, Fagnani F, Phillippo M, Pribil C, Charles MA, Sermet C, et al. Obesity morbidity and health care costs in France: an analysis of the 1991–1992 Medical Care Household Survey. Int J Obes Relat Metab Disord. 2000;24(2):151–5.
Levy E, Levy P, Le PC, Basdevant A. The economic cost of obesity: the French situation. Int J Obes Relat Metab Disord. 1995;19(11):788–92.
Report by the Comptroller and Auditor General. Tackling Obesity in England. 2001. HC 220 Session 2000–2001; 2001 Feb 15.
Esposti ED, Sturani A, Valpiani G, Di MM, Ziccardi F, Rita CA, et al. The relationship between body weight and drug costs: an Italian population-based study. Clin Ther. 2006;28(9):1472–81.
Schmid A, Schneider H, Golay A, Keller U. Economic burden of obesity and its comorbidities in Switzerland. Soz Praventivmed. 2005;50(2):87–94.
Golay A, Masciangelo ML. Burden of obesity: from epidemic to costs. Rev Med Suisse. 2005;1(12):807–10,813.
Seidell JC. The impact of obesity on health status: some implications for health care costs. Int J Obes Relat Metab Disord. 1995;19(Suppl 6):S13–6.
James WPT, Jackson-Leach R, Ni Mhurchu C. Overweight and obesity (high body mass index). In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. vol 1. Geneva: WHO; 2004.
Birmingham CL, Muller JL, Palepu A, Spinelli JJ, Anis AH. The cost of obesity in Canada. CMAJ. 1999;160(4):483–8.
Katzmarzyk PT, Janssen I. The economic costs associated with physical inactivity and obesity in Canada: an update. Can J Appl Physiol. 2004;29(1):90–115.
Swinburn B, Ashton T, Gillespie J, Cox B, Menon A, Simmons D, et al. Health care costs of obesity in New Zealand. Int J Obes Relat Metab Disord. 1997;21(10):891–6.
Colditz GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc. 1999;31(11 Suppl):S663–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Müller-Riemenschneider, F., Reinhold, T., Berghöfer, A. et al. Health-economic burden of obesity in Europe. Eur J Epidemiol 23, 499–509 (2008). https://doi.org/10.1007/s10654-008-9239-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-008-9239-1